The practical roadmap for peri-cystectomy approaches in muscle-invasive bladder cancer [PDF]
Frontiers in OncologyThe management of muscle-invasive bladder cancer (MIBC) remains a challenging topic since it is witnessing rapidly evolving changes and new drug approvals. In fact, more effective approaches are now available to improve the outcomes of patients with MIBC
Joseph Kattan +3 more
doaj +2 more sources
Survival benefits of postoperative adjuvant chemotherapy in adults aged ≥ 80 years with locally advanced gastric cancer: insights from a population-based study [PDF]
Discover OncologyBackground and aims Postoperative adjuvant chemotherapy in older adults aged ≥ 80 years with locally advanced gastric cancer (LAGC) remains debated owing to concerns over treatment tolerance and limited data.
Fuhai Ma +11 more
doaj +2 more sources
Chemotherapy adjuvant and chemotherapy-induced neutropenia
Taiwanese Journal of Obstetrics & Gynecology, 2022 Yiu-Tai Li, Szu-Ting Yang, Peng-Hui Wang
doaj +3 more sources
Metronomic adjuvant chemotherapy evaluation in locally advanced head and neck cancers post radical chemoradiation – a randomised trial [PDF]
, 2023 Background: Locally advanced head and neck cancers treated with radical chemoradiation have unsatisfactory outcomes. Oral metronomic chemotherapy improves outcomes in comparison to maximum tolerated dose chemotherapy in the palliative setting.
Banavali, Shripad +8 more
core +3 more sources
CA: A Cancer Journal for Clinicians, 1986 At present, adjuvant chemotherapy exerts no significant impact on long-term survival and only occasionally provides brief palliation in head and neck cancer. The major contribution of chemotherapy has been in the preoperative period, when therapy for advanced squamous cell carcinoma may render some patients candidates for curative operations or ...
Charles A. Coltman, C. Kent Osborne
openaire +5 more sources
Update on Adjuvant Treatment in Resectable Non-Small Cell Lung Cancer and Potential Biomarkers Predicting Postoperative Relapse [PDF]
Tuberculosis and Respiratory Diseases, 2023 A significant proportion of patients with non-small cell lung cancer (NSCLC) is diagnosed in the early and resectable stage. Despite the use of platinum-based adjuvant chemotherapy, there was only a marginal increase in overall survival and a 15 ...
Jeong Uk Lim
doaj +1 more source
Novel molecular classification of endometrial cancer - current and future clinical implications [PDF]
Vojnosanitetski Pregled, 2023 nema
Mandić Aljoša +4 more
doaj +1 more source
Clinical efficacy of adjuvant chemotherapy in stage IB (< 4 cm) non-small cell lung cancer patients with high-risk factors [PDF]
The Korean Journal of Internal Medicine, 2022 Background/Aims Adjuvant chemotherapy is the standard of care for resected stage II–IIIA non-small cell lung cancer (NCSLC). The efficacy of adjuvant chemotherapy in stage IB (< 4 cm) NSCLC with high-risk factors is controversial.
Juwhan Choi +12 more
doaj +1 more source
Annals of Gastroenterological Surgery, 2023 Aim We aimed to clarify the use of adjuvant chemotherapy and the prognosis of elderly colorectal cancer patients compared with non‐elderly patients, and the usefulness of sarcopenia as an indicator for the introduction and completion of adjuvant ...
Takuya Shiraishi +8 more
doaj +1 more source
Adjuvant chemotherapy for medulloblastoma [PDF]
Cancer, 1985 The use of adjuvant chemotherapy for cerebellar medulloblastoma is controversial. Twenty-one children and adolescents were treated with adjuvant low-dose cyclophosphamide and vincristine following surgery and radiotherapy. With a mean observation period of 6 years, the disease-free survival is 81%.
Sue McIntosh +7 more
openaire +3 more sources